GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IR Biosciences Holdings Inc (GREY:IRBS) » Definitions » Pretax Margin %

IR Biosciences Holdings (IR Biosciences Holdings) Pretax Margin % : % (As of Dec. 2010)


View and export this data going back to . Start your Free Trial

What is IR Biosciences Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. IR Biosciences Holdings's Pre-Tax Income for the three months ended in Dec. 2010 was $-0.34 Mil. IR Biosciences Holdings's Revenue for the three months ended in Dec. 2010 was $0.00 Mil. Therefore, IR Biosciences Holdings's pretax margin for the quarter that ended in Dec. 2010 was %.

The historical rank and industry rank for IR Biosciences Holdings's Pretax Margin % or its related term are showing as below:


IRBS's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.52
* Ranked among companies with meaningful Pretax Margin % only.

IR Biosciences Holdings Pretax Margin % Historical Data

The historical data trend for IR Biosciences Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR Biosciences Holdings Pretax Margin % Chart

IR Biosciences Holdings Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IR Biosciences Holdings Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IR Biosciences Holdings's Pretax Margin %

For the Biotechnology subindustry, IR Biosciences Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IR Biosciences Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IR Biosciences Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where IR Biosciences Holdings's Pretax Margin % falls into.



IR Biosciences Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

IR Biosciences Holdings's Pretax Margin for the fiscal year that ended in Dec. 2010 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=-5.282/0
= %

IR Biosciences Holdings's Pretax Margin for the quarter that ended in Dec. 2010 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2010 )/Revenue (Q: Dec. 2010 )
=-0.343/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IR Biosciences Holdings  (GREY:IRBS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


IR Biosciences Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of IR Biosciences Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


IR Biosciences Holdings (IR Biosciences Holdings) Business Description

Traded in Other Exchanges
N/A
Address
8777 E. Via De Ventura, Suite 280, Scottsdale, AZ, USA, 85258
IR Biosciences Holdings Inc is a development-stage biotechnology company engaged in the research & development of potential drug candidate, Homspera and its derivatives, Radilex and Viprovex through its subsidiary, ImmuneRegen BioSciences, Inc. It is engaged in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia.

IR Biosciences Holdings (IR Biosciences Holdings) Headlines

No Headlines